title: Influence of baseline protease inhibitor resistance on the efficacy of darunavir/ritonavir or lopinavir/ritonavir in the TITAN trial.
authors.forename: Sandra
authors.initials: S
authors.lastname: De Meyer
authors.forename: Andrew
authors.initials: A
authors.lastname: Hill
authors.forename: Gaston
authors.initials: G
authors.lastname: Picchio
authors.forename: Ralph
authors.initials: R
authors.lastname: DeMasi
authors.forename: Els
authors.initials: E
authors.lastname: De Paepe
authors.forename: Marie-Pierre
authors.initials: MP
authors.lastname: de Béthune
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D000069454:Darunavir; D024921:Drug Resistance, Multiple, Viral; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics; D006801:Humans; D061466:Lopinavir; D009154:Mutation; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D011744:Pyrimidinones / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D019438:Ritonavir / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D013449:Sulfonamides / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D011480:Protease Inhibitors; D011744:Pyrimidinones; D013449:Sulfonamides; D061466:Lopinavir; D019438:Ritonavir; D000069454:Darunavir